852 results on '"Burmester, Gerd-Rüdiger"'
Search Results
2. Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
3. Therapeutische Antikörper in der Rheumatologie
4. Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis
5. Digital health information on autoinflammatory diseases: a YouTube quality analysis
6. Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen?
7. 80 Meilensteine der Rheumatologie aus 80 Jahren – III: 1980–2000
8. Nuclear antigen–reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys
9. Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
10. Fibrinogen, factor XIII and α2-antiplasmin genotypes are associated with inflammatory activity and anti-citrullinated protein antibodies
11. Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
12. Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany
13. Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2
14. Pathogenic memory plasma cells in autoimmunity
15. Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial
16. Are prognostic factors adequately selected to guide treatment decisions in patients with rheumatoid arthritis? A collaborative analysis from three observational cohorts
17. Prophylactic antibodies inhibit spike‐specific T and B cell responses after COVID‐19 vaccination.
18. Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges.
19. Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis
20. Therapeutic antibodies in rheumatology
21. Nachruf der Deutschen Gesellschaft für Rheumatologie auf Prof. Joachim R. Kalden
22. Autologous Stem Cell Transplantation in Relapsing Polychondritis
23. Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
24. Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
25. The proteasome — victim or culprit in autoimmunity
26. Das Was, Wie und Warum in der rheumatologischen Versorgung
27. Fluorescence optical imaging for treatment monitoring in patients with early and active rheumatoid arthritis in a 1-year follow-up period
28. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
29. Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options
30. Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis
31. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
32. Digital health information on autoinflammatory diseases: a YouTube quality analysis
33. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
34. Glucocorticoids
35. 30 - Laboratory tests in rheumatic disorders
36. Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity
37. Die 'ARIAA-Studie' – Abatacept verzögert den Übergang in eine RA bei at-risk-Patienten – klinische Ergebnisse zu Monat 18 der internationalen, randomisiert, placebo kontrollierten Studie
38. B cell characteristics and total numbers predict SARS-CoV-2 vaccination response among patients treated with rituximab
39. Pre-exposure prophylaxis using SARS-CoV-2 neutralizing antibodies suppresses the specific cellular immune response to mRNA vaccination in rheumatic patients
40. Add-on or withdrawal of methotrexate do not impact efficacy of IL12/23 inhibition in active PsA: Data from the multicenter investigator-initiated randomized placebo-controlled MUST trial
41. A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren’s syndrome
42. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients
43. Disentangling the effects of tocilizumab on neutrophil survival and function
44. SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis
45. Correspondence
46. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
47. Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans
48. Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers
49. A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
50. Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.